BCYRN1 and hepatocellular carcinoma: Our outcomes suggested that BCYRN1, miR-490-3p, and POU3F2 formed a ceRNA mechanism to modulate the occurrence and progression of HCC, providing a theoretical basis for searching neoteric target molecules for the treatment of HCC.